Thank you to all those who attended the Yale Cancer Center Scientific Retreat on May 18th. The day was highly successful and effectively outlined a vision for Yale Cancer Center's research priorities over the next several years as we build on our current programs and transition to the West Campus. The Shared Resources provided a great overview during a terrific poster session that outlined their capabilities. We are planning to have another poster session and reception on campus in the coming weeks for those who were not able to attend. Details will follow.
Program Planning and Review
Starting next month, senior cancer center leadership will meet with the leadership of each research program to review its progress at the "midpoint" of the current cancer center support grant (CCSG) cycle. During this process each program will be reviewed to determine its commitment to inter and intra-programmatic research and to address how it has responded to both the "pink sheets" from the 2007 CCSG and the External Scientific Advisory Board comments from 2007. Finally, the leadership of each program will discuss their plans for how they will approach the resubmission of the CCSG in 2012.
CCSG Annual Review
The annual review for the cancer center support grant has been finalized and will be sent to the NCI shortly. A special thanks to Cathy Vellucci, Jennifer Mulligan, and their staff for all of their efforts and hard work on the Review.
I am pleased to announce a new mini-cabinet of leaders who will help to oversee the clinical integration of cancer programs and transition into Smilow Cancer Hospital. Committee members working with me include: Tracy Carafeno, RN, Marianne Dess-Santoro, Abe Lopman, Peter Marks, MD, Thomas Rutherford, MD, Tahiry Sanchez, RN, Cathy Vellucci, David Vinas, and Lynn Wilson, MD.
Deputy Director for Administration
It is with mixed feelings that I report to you that Cathy Vellucci has accepted another position at Yale University on the main campus. While I am happy for her as she moves on to a new challenge, her expertise, knowledge, and commitment will be greatly missed. Cathy has been a wonderful asset to YCC over the last few years and has helped the Center through many difficult obstacles. Please join me in wishing Cathy the best in her new endeavors at Yale. A search for a new Deputy Director for Administration will launch this summer.
There are 410 construction workers on site daily working to complete different areas of the building. The exterior of the Smilow Cancer Hospital is closed in and the roof is now 95% complete. Inside, the lobby is beginning to take shape; the glass and Terrazzo flooring has been installed. The sheetrock continues to be added to all of the interior walls and the basement, first, and second floors are looking more complete with the addition of the cabinetry and millwork finishes.
The Shared Resources Section of Yale Cancer Center is dedicated to the support of the Cancer Center Core Programs. There are 11 Shared Resources and 4 Developing Shared Resources. For the remainder of the year, each issue of DirectConnect will highlight a different existing or developing Shared Resource. There will be a brief overview of the Resource, links to their web page, and a number to contact for further information. It is our intent to increase the visibility of the Resources available within YCC that support the Cancer Center's Research Programs. We hope you will read this section bimonthly and contact the Resource Director with any questions. Also, please feel free to contact Edward Snyder, MD, Associate Director of Shared Resources, at 688-2441.
Whole Pelvic Radiotherapy Versus Prostate Only Radiotherapy in THE Management of Locally Advanced or Aggressive Prostate Adenocarcinoma.
Aizer AA, Yu JB, McKeon AM, Decker RH, Colberg JW, Peschel RE. Int J Radiat Oncol Biol Phys. 2009 May 21.
Read More >>
Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis.
Yi CH, Zheng T, Leaderer D, Hoffman A, Zhu Y.
Cancer Lett. 2009 May 18.
Read More >>
Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer.